Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Takotsubo Cardiomyopathy | 6 | 2023 | 63 | 1.710 |
Why?
|
Obesity | 10 | 2023 | 1178 | 1.630 |
Why?
|
Pericardium | 5 | 2023 | 35 | 1.540 |
Why?
|
Coronary Artery Disease | 3 | 2023 | 265 | 1.390 |
Why?
|
Atrial Fibrillation | 6 | 2023 | 794 | 1.380 |
Why?
|
Cardiomyopathies | 4 | 2023 | 119 | 1.370 |
Why?
|
Ventricular Remodeling | 4 | 2020 | 80 | 1.150 |
Why?
|
Intra-Abdominal Fat | 2 | 2019 | 38 | 1.110 |
Why?
|
Ventricular Function, Left | 4 | 2020 | 262 | 0.860 |
Why?
|
Heart Valve Diseases | 3 | 2023 | 86 | 0.820 |
Why?
|
Blood Vessels | 2 | 2014 | 61 | 0.810 |
Why?
|
Electrocardiography | 7 | 2022 | 521 | 0.790 |
Why?
|
Adipose Tissue | 5 | 2023 | 283 | 0.780 |
Why?
|
Cardiovascular Diseases | 3 | 2014 | 820 | 0.770 |
Why?
|
Inflammation Mediators | 2 | 2019 | 169 | 0.730 |
Why?
|
Pheochromocytoma | 1 | 2020 | 27 | 0.720 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2020 | 45 | 0.710 |
Why?
|
Diagnostic Imaging | 2 | 2013 | 240 | 0.700 |
Why?
|
Atherosclerosis | 3 | 2016 | 147 | 0.700 |
Why?
|
Lipolysis | 1 | 2020 | 47 | 0.690 |
Why?
|
Heart Failure | 4 | 2018 | 859 | 0.680 |
Why?
|
Echocardiography | 5 | 2023 | 455 | 0.670 |
Why?
|
Adiposity | 2 | 2023 | 79 | 0.650 |
Why?
|
Vascular Diseases | 2 | 2016 | 69 | 0.620 |
Why?
|
Echocardiography, Doppler | 2 | 2018 | 130 | 0.620 |
Why?
|
Insulin | 2 | 2020 | 682 | 0.600 |
Why?
|
Adipocytes | 4 | 2023 | 251 | 0.570 |
Why?
|
Adipose Tissue, Brown | 2 | 2023 | 98 | 0.550 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2016 | 5 | 0.530 |
Why?
|
Coronary Vessel Anomalies | 1 | 2016 | 15 | 0.530 |
Why?
|
Methylprednisolone | 1 | 2015 | 29 | 0.510 |
Why?
|
Bradycardia | 1 | 2015 | 34 | 0.500 |
Why?
|
Humans | 35 | 2023 | 58855 | 0.500 |
Why?
|
Insulin Resistance | 2 | 2016 | 397 | 0.500 |
Why?
|
Cardiac Catheterization | 2 | 2016 | 239 | 0.490 |
Why?
|
Aortic Valve Insufficiency | 1 | 2015 | 40 | 0.480 |
Why?
|
Glucocorticoids | 1 | 2015 | 167 | 0.460 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2014 | 107 | 0.450 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 248 | 0.450 |
Why?
|
Diastole | 3 | 2023 | 89 | 0.440 |
Why?
|
Lectins, C-Type | 1 | 2013 | 82 | 0.430 |
Why?
|
Inflammation | 4 | 2017 | 1096 | 0.420 |
Why?
|
Myocardial Infarction | 2 | 2017 | 852 | 0.420 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 133 | 0.420 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 204 | 0.420 |
Why?
|
Outpatients | 1 | 2013 | 131 | 0.410 |
Why?
|
Ventricular Premature Complexes | 2 | 2022 | 21 | 0.380 |
Why?
|
Macrophages | 2 | 2016 | 1000 | 0.370 |
Why?
|
Coronary Angiography | 3 | 2019 | 168 | 0.360 |
Why?
|
Biomarkers, Tumor | 1 | 2013 | 452 | 0.350 |
Why?
|
Thinness | 1 | 2009 | 38 | 0.340 |
Why?
|
Thermogenesis | 3 | 2023 | 107 | 0.330 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2020 | 160 | 0.330 |
Why?
|
Heart Failure, Diastolic | 1 | 2009 | 9 | 0.330 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2009 | 47 | 0.310 |
Why?
|
Heart Atria | 3 | 2023 | 137 | 0.300 |
Why?
|
Middle Aged | 13 | 2021 | 16127 | 0.300 |
Why?
|
Male | 17 | 2023 | 27275 | 0.290 |
Why?
|
Stroke Volume | 2 | 2018 | 317 | 0.280 |
Why?
|
Diet | 1 | 2011 | 631 | 0.270 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 522 | 0.270 |
Why?
|
Female | 17 | 2020 | 30564 | 0.260 |
Why?
|
Body Mass Index | 1 | 2009 | 890 | 0.250 |
Why?
|
Prognosis | 4 | 2018 | 1561 | 0.250 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 1020 | 0.240 |
Why?
|
Systole | 2 | 2015 | 109 | 0.230 |
Why?
|
Aged | 11 | 2020 | 13215 | 0.230 |
Why?
|
Practice Patterns, Physicians' | 1 | 2009 | 708 | 0.230 |
Why?
|
Heart Ventricles | 3 | 2023 | 247 | 0.230 |
Why?
|
Heart Valves | 2 | 2023 | 22 | 0.220 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2023 | 34 | 0.210 |
Why?
|
Glutamine | 1 | 2023 | 47 | 0.210 |
Why?
|
Fibrosis | 1 | 2023 | 151 | 0.210 |
Why?
|
Massachusetts | 4 | 2013 | 2076 | 0.200 |
Why?
|
Animals | 10 | 2023 | 19494 | 0.200 |
Why?
|
Myocardial Ischemia | 2 | 2017 | 107 | 0.200 |
Why?
|
Isolated Noncompaction of the Ventricular Myocardium | 1 | 2021 | 3 | 0.190 |
Why?
|
Infarction, Posterior Cerebral Artery | 1 | 2021 | 7 | 0.190 |
Why?
|
Wearable Electronic Devices | 1 | 2022 | 63 | 0.190 |
Why?
|
Atrial Premature Complexes | 1 | 2021 | 13 | 0.190 |
Why?
|
Glucose | 2 | 2023 | 440 | 0.190 |
Why?
|
Adrenergic Agents | 1 | 2020 | 16 | 0.180 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2020 | 5 | 0.180 |
Why?
|
Diet, Reducing | 1 | 2020 | 31 | 0.180 |
Why?
|
Uncoupling Protein 1 | 3 | 2020 | 47 | 0.170 |
Why?
|
Subcutaneous Fat | 1 | 2019 | 49 | 0.160 |
Why?
|
Oxygen Consumption | 2 | 2020 | 196 | 0.160 |
Why?
|
Hypertension | 1 | 2005 | 598 | 0.160 |
Why?
|
Muscle, Skeletal | 2 | 2023 | 668 | 0.160 |
Why?
|
Weight Gain | 1 | 2020 | 161 | 0.160 |
Why?
|
Cytokines | 3 | 2017 | 903 | 0.160 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2019 | 291 | 0.150 |
Why?
|
Apolipoproteins E | 2 | 2015 | 99 | 0.150 |
Why?
|
RNA, Long Noncoding | 1 | 2020 | 150 | 0.150 |
Why?
|
Risk Assessment | 3 | 2018 | 1893 | 0.150 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2017 | 91 | 0.140 |
Why?
|
Lectins | 1 | 2017 | 38 | 0.140 |
Why?
|
Adipogenesis | 1 | 2018 | 71 | 0.140 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 60 | 0.140 |
Why?
|
Prevalence | 3 | 2010 | 1277 | 0.140 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 693 | 0.130 |
Why?
|
Risk Factors | 4 | 2018 | 4975 | 0.130 |
Why?
|
Interferon Type I | 1 | 2017 | 169 | 0.130 |
Why?
|
Pulse Therapy, Drug | 1 | 2015 | 2 | 0.130 |
Why?
|
Stem Cells | 1 | 2018 | 254 | 0.130 |
Why?
|
NADPH Oxidases | 1 | 2015 | 64 | 0.130 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 112 | 0.120 |
Why?
|
Mice | 7 | 2023 | 10192 | 0.120 |
Why?
|
Neovascularization, Physiologic | 1 | 2016 | 102 | 0.120 |
Why?
|
Infusions, Intravenous | 1 | 2015 | 170 | 0.120 |
Why?
|
Aged, 80 and over | 5 | 2020 | 5046 | 0.120 |
Why?
|
Ion Channels | 2 | 2016 | 86 | 0.120 |
Why?
|
Time Factors | 3 | 2018 | 3544 | 0.120 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2016 | 148 | 0.120 |
Why?
|
Glucose Intolerance | 1 | 2016 | 88 | 0.120 |
Why?
|
Mice, Inbred C57BL | 4 | 2018 | 3158 | 0.120 |
Why?
|
Mitochondrial Proteins | 2 | 2016 | 99 | 0.120 |
Why?
|
Brain Ischemia | 1 | 2018 | 403 | 0.120 |
Why?
|
Reactive Oxygen Species | 1 | 2015 | 201 | 0.120 |
Why?
|
Endothelial Cells | 1 | 2015 | 175 | 0.120 |
Why?
|
Lipid Metabolism | 1 | 2016 | 203 | 0.120 |
Why?
|
Pancreatitis-Associated Proteins | 1 | 2013 | 4 | 0.110 |
Why?
|
Autophagy | 1 | 2016 | 205 | 0.110 |
Why?
|
Follow-Up Studies | 3 | 2014 | 2316 | 0.110 |
Why?
|
RNA, Messenger | 2 | 2016 | 1460 | 0.110 |
Why?
|
Blood Glucose | 1 | 2016 | 467 | 0.110 |
Why?
|
ROC Curve | 1 | 2013 | 259 | 0.110 |
Why?
|
Treatment Outcome | 2 | 2016 | 5099 | 0.100 |
Why?
|
Severity of Illness Index | 2 | 2017 | 1441 | 0.100 |
Why?
|
Cause of Death | 1 | 2013 | 200 | 0.100 |
Why?
|
Photoplethysmography | 2 | 2022 | 33 | 0.100 |
Why?
|
Algorithms | 3 | 2022 | 981 | 0.100 |
Why?
|
Mitochondria, Heart | 1 | 2011 | 12 | 0.100 |
Why?
|
Microarray Analysis | 1 | 2011 | 56 | 0.090 |
Why?
|
Survival Rate | 1 | 2013 | 783 | 0.090 |
Why?
|
Prospective Studies | 2 | 2021 | 3074 | 0.090 |
Why?
|
Retrospective Studies | 5 | 2018 | 5922 | 0.090 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2022 | 98 | 0.090 |
Why?
|
Torsades de Pointes | 1 | 2010 | 5 | 0.090 |
Why?
|
Aorta, Thoracic | 1 | 2011 | 77 | 0.090 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2011 | 135 | 0.090 |
Why?
|
Neutrophil Infiltration | 1 | 2011 | 61 | 0.090 |
Why?
|
Long QT Syndrome | 1 | 2010 | 28 | 0.090 |
Why?
|
Heart Rate | 2 | 2022 | 302 | 0.090 |
Why?
|
Dietary Fats | 1 | 2011 | 201 | 0.090 |
Why?
|
Stroke | 1 | 2018 | 1135 | 0.080 |
Why?
|
Flow Cytometry | 1 | 2011 | 667 | 0.080 |
Why?
|
Immunohistochemistry | 1 | 2011 | 846 | 0.080 |
Why?
|
Cells, Cultured | 3 | 2020 | 2090 | 0.080 |
Why?
|
Heart Failure, Systolic | 1 | 2009 | 16 | 0.080 |
Why?
|
Cardiotonic Agents | 1 | 2009 | 48 | 0.080 |
Why?
|
Disease Progression | 1 | 2013 | 1030 | 0.080 |
Why?
|
Biomarkers | 1 | 2013 | 1199 | 0.080 |
Why?
|
Acute Disease | 1 | 2009 | 650 | 0.070 |
Why?
|
Odds Ratio | 1 | 2009 | 769 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2009 | 185 | 0.070 |
Why?
|
Mice, Knockout | 3 | 2017 | 1981 | 0.070 |
Why?
|
Ultrasonography | 1 | 2009 | 447 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 893 | 0.070 |
Why?
|
Logistic Models | 1 | 2009 | 1245 | 0.070 |
Why?
|
Aorta | 2 | 2018 | 103 | 0.070 |
Why?
|
Age Factors | 1 | 2009 | 1516 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2009 | 840 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2009 | 438 | 0.060 |
Why?
|
Signal Transduction | 1 | 2014 | 2881 | 0.060 |
Why?
|
Cohort Studies | 1 | 2009 | 2428 | 0.050 |
Why?
|
Artifacts | 1 | 2022 | 126 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 1535 | 0.050 |
Why?
|
Perilipin-1 | 1 | 2020 | 12 | 0.040 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2020 | 55 | 0.040 |
Why?
|
Lipid Droplets | 1 | 2020 | 27 | 0.040 |
Why?
|
Cell Communication | 1 | 2020 | 129 | 0.040 |
Why?
|
Machine Learning | 1 | 2021 | 135 | 0.040 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2017 | 45 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2020 | 344 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2017 | 35 | 0.040 |
Why?
|
Adipokines | 1 | 2017 | 26 | 0.040 |
Why?
|
Disability Evaluation | 1 | 2018 | 214 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2020 | 601 | 0.030 |
Why?
|
Proprotein Convertase 1 | 1 | 2016 | 5 | 0.030 |
Why?
|
Enkephalins | 1 | 2016 | 15 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 17 | 0.030 |
Why?
|
Interleukin-33 | 1 | 2016 | 18 | 0.030 |
Why?
|
Iodide Peroxidase | 1 | 2016 | 22 | 0.030 |
Why?
|
Cell Transplantation | 1 | 2016 | 39 | 0.030 |
Why?
|
Integrin beta1 | 1 | 2016 | 28 | 0.030 |
Why?
|
Capillaries | 1 | 2016 | 30 | 0.030 |
Why?
|
Glucose Clamp Technique | 1 | 2016 | 56 | 0.030 |
Why?
|
Receptors, LDL | 1 | 2015 | 33 | 0.030 |
Why?
|
United States | 1 | 2009 | 7438 | 0.030 |
Why?
|
Aminopyridines | 1 | 2015 | 22 | 0.030 |
Why?
|
Adipocytes, White | 1 | 2016 | 27 | 0.030 |
Why?
|
Protein Precursors | 1 | 2016 | 70 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2016 | 95 | 0.030 |
Why?
|
Aortic Valve | 1 | 2017 | 163 | 0.030 |
Why?
|
NADPH Oxidase 4 | 1 | 2015 | 5 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 220 | 0.030 |
Why?
|
Transcription Factors | 1 | 2023 | 1450 | 0.030 |
Why?
|
Adipocytes, Brown | 1 | 2016 | 44 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 104 | 0.030 |
Why?
|
Transcriptome | 1 | 2018 | 318 | 0.030 |
Why?
|
Diet, High-Fat | 1 | 2016 | 156 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2015 | 191 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 498 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2015 | 171 | 0.030 |
Why?
|
Blotting, Western | 1 | 2015 | 591 | 0.030 |
Why?
|
Phenotype | 1 | 2018 | 1151 | 0.030 |
Why?
|
NF-kappa B | 1 | 2015 | 461 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2015 | 278 | 0.030 |
Why?
|
Homeostasis | 1 | 2016 | 333 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2015 | 194 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2015 | 536 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 671 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2015 | 1218 | 0.020 |
Why?
|
Adult | 2 | 2020 | 15602 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2015 | 936 | 0.020 |
Why?
|
Young Adult | 1 | 2020 | 4275 | 0.020 |
Why?
|
Proteins | 1 | 2016 | 741 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 1126 | 0.020 |
Why?
|